Fjarde Ap-fonden’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.4M Sell
549,324
-11,700
-2% -$1.02M 0.24% 83
2026
Q1
$47.8M Buy
561,024
+215,300
+62% +$19.2M 0.26% 79
2025
Q4
$27.3M Buy
345,724
+15,200
+5% +$1.19M 0.23% 90
2025
Q3
$26.4M Buy
330,524
+1,040
+0.3% +$88.7K 0.23% 91
2025
Q2
$29.9M Buy
329,484
+103,000
+45% +$9.4M 0.28% 80
2025
Q1
$21.2M Sell
226,484
-107,800
-32% -$9.65M 0.25% 82
2024
Q4
$30.4M Buy
334,284
+97,700
+41% +$9.32M 0.31% 58
2024
Q3
$24.6M Buy
+236,584
New +$24.1M 0.25% 78
2024
Q1
$18.4M Buy
203,889
+6,600
+3% +$559K 0.2% 105
2023
Q4
$15.7M Buy
197,289
+7,500
+4% +$564K 0.2% 108
2023
Q3
$13.5M Sell
189,789
-26,200
-12% -$1.96M 0.18% 116
2023
Q2
$16.6M Sell
215,989
-1,700
-0.8% -$132K 0.2% 100
2023
Q1
$16.4M Sell
217,689
-29,500
-12% -$2.19M 0.22% 103
2022
Q4
$19.5M Sell
247,189
-45,136
-15% -$3.38M 0.28% 79
2022
Q3
$23.4M Hold
292,325
0.29% 66
2022
Q2
$23.4M Buy
292,325
+74,700
+34% +$5.84M 0.29% 66
2022
Q1
$16.5M Sell
217,625
-59,684
-22% -$4.73M 0.16% 123
2021
Q4
$23.7M Buy
277,309
+8,115
+3% +$634K 0.21% 95
2021
Q3
$20.3M Sell
269,194
-8,400
-3% -$667K 0.19% 107
2021
Q2
$22.6M Buy
277,594
+600
+0.2% +$49.1K 0.21% 104
2021
Q1
$21.8M Buy
276,994
+17,400
+7% +$1.36M 0.2% 104
2020
Q4
$22.2M Buy
259,594
+4,900
+2% +$405K 0.21% 96
2020
Q3
$19.6M Buy
254,694
+13,300
+6% +$1.01M 0.21% 93
2020
Q2
$17.7M Buy
241,394
+35,800
+17% +$2.54M 0.22% 95
2020
Q1
$13.6M Sell
205,594
-117,700
-36% -$8.3M 0.22% 101
2019
Q4
$22.3M Buy
323,294
+3,000
+0.9% +$205K 0.27% 71
2019
Q3
$23.5M Buy
320,294
+12,632
+4% +$916K 0.31% 71
2019
Q2
$22.1M Sell
307,662
-6,700
-2% -$476K 0.28% 73
2019
Q1
$21.5M Buy
314,362
+32,351
+11% +$2.09M 0.27% 73
2018
Q4
$16.8M Buy
282,011
+68,200
+32% +$4.27M 0.29% 68
2018
Q3
$14.3M Buy
213,811
+24
+0% +$1.6K 0.21% 101
2018
Q2
$13.9M Buy
213,787
+20,015
+10% +$1.31M 0.21% 106
2018
Q1
$13.9M Sell
193,772
-791
-0.4% -$56.9K 0.21% 101
2017
Q4
$14.7M Buy
194,563
+28,334
+17% +$2.07M 0.22% 103
2017
Q3
$12.1M Sell
166,229
-1,077
-0.6% -$77.6K 0.23% 95
2017
Q2
$12.4M Buy
167,306
+25,241
+18% +$1.87M 0.25% 90
2017
Q1
$10.4M Sell
142,065
-13,655
-9% -$956K 0.25% 88
2016
Q4
$10.2M Sell
155,720
-13,518
-8% -$927K 0.24% 92
2016
Q3
$12.5M Buy
169,238
+19,774
+13% +$1.46M 0.27% 78
2016
Q2
$10.9M Sell
149,464
-35,301
-19% -$2.51M 0.25% 87
2016
Q1
$13.1M Buy
184,765
+21,889
+13% +$1.46M 0.3% 74
2015
Q4
$10.9M Buy
162,876
+2,311
+1% +$154K 0.29% 75
2015
Q3
$10.2M Sell
160,565
-19,319
-11% -$1.26M 0.28% 76
2015
Q2
$11.8M Sell
179,884
-25,341
-12% -$1.72M 0.28% 76
2015
Q1
$14.2M Sell
205,225
-15,762
-7% -$1.09M 0.33% 69
2014
Q4
$15.3M Sell
220,987
-9,663
-4% -$653K 0.33% 67
2014
Q3
$15M Sell
230,650
-19,412
-8% -$1.28M 0.32% 68
2014
Q2
$17M Sell
250,062
-14,965
-6% -$1M 0.34% 71
2014
Q1
$17.2M Buy
265,027
+9,034
+4% +$569K 0.34% 66
2013
Q4
$16.7M Sell
255,993
-18,666
-7% -$1.19M 0.35% 60
2013
Q3
$16.3M Sell
274,659
-25,865
-9% -$1.53M 0.35% 61
2013
Q2
$17.2M Buy
+300,524
New +$17.8M 0.36% 57

Other funds holding CL

Fjarde Ap-fonden's CL Position: Q2 2026 in Review

Fjarde Ap-fonden reduced its Colgate-Palmolive (CL) stake by 2.1% in Q2 2026, selling an estimated $1.02M and leaving 549,324 shares worth $50.4M. The position accounts for 0.24% of the portfolio, ranked #83.

Fjarde Ap-fonden first reported a position in CL in Q2 2013 and has held it in 52 quarters since. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Fjarde Ap-fonden held 549,324 shares of Colgate-Palmolive worth $50.4M as of Q2 2026.
  • Fjarde Ap-fonden sold 11,700 Colgate-Palmolive shares in Q2 2026, an estimated $1.02M.
  • Colgate-Palmolive made up 0.24% of Fjarde Ap-fonden's portfolio in Q2 2026, its #83 holding.
  • Fjarde Ap-fonden first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.